Q2 2014

Filed Aug 13, 2014 · 10-Q · 44 days after period end · 0001121781-14-000235

Q2 2014 · 10-Q

Revenue

$11.00K

−95.0% vs Q2 2013

Net Income

-$2.15M

N/M vs Q2 2013

EPS Diluted

-$0.03

N/M vs Q2 2013

Gross Profit-$70,000N/M

Operating Income

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$11.00K	$222.00K	$915.00K	$913.00K
Net Income	-$2.15M	-$1.75M	-$1.17M	-$496.00K
EPS Diluted	-$0.03	-$0.04	-$0.02	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR